Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 73 entries
Sorted by: Best Match Show Resources per page
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Robert G, Delongchamps NB, Descazeaud A, Bénard A, Azzouzi R, Saussine C, De la Taille A, Fourmarier M, Karsenty G, Desgrandchamps F, Faix A, Pasticier G, Bernhard J, Ferrière J, Ballanger P.
PMID: 26544470
Prog Urol. 2015 Nov;25(13):853-4. doi: 10.1016/j.purol.2015.08.276.

No abstract available.

Cite
Robert G, Delongchamps NB, Descazeaud A, et al. Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX. [Not Available]. Prog Urol. 2015;25(13):853-4doi: 10.1016/j.purol.2015.08.276.
Robert, G., Delongchamps, N. B., Descazeaud, A., Bénard, A., Azzouzi, R., Saussine, C., De la Taille, A., Fourmarier, M., Karsenty, G., Desgrandchamps, F., Faix, A., Pasticier, G., Bernhard, J., Ferrière, J., & Ballanger, P. (2015). Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 853-4. https://doi.org/10.1016/j.purol.2015.08.276
Robert, G, et al. "Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 853-4. doi: https://doi.org/10.1016/j.purol.2015.08.276
Robert G, Delongchamps NB, Descazeaud A, Bénard A, Azzouzi R, Saussine C, De la Taille A, Fourmarier M, Karsenty G, Desgrandchamps F, Faix A, Pasticier G, Bernhard J, Ferrière J, Ballanger P. Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX. [Not Available]. Prog Urol. 2015 Nov;25(13):853-4. doi: 10.1016/j.purol.2015.08.276. French. PMID: 26544470.
Copy Download .nbib Format: NLM
Nickel and iron complexes with oxazoline- or pyridine-phosphonite ligands; synthesis, structure and application for the catalytic oligomerisation of ethylene.

Dalton transactions (Cambridge, England : 2003)

Speiser F, Braunstein P, Saussine L.
PMID: 15252602
Dalton Trans. 2004 May 21;(10):1539-45. doi: 10.1039/b401792g. Epub 2004 Apr 20.

The bis(oxazolinyl)phenylphosphonite ligand (bis(4,4-dimethyl-2-(1-hydroxy-1-methylethyl)-4,5-dihydrooxazole)phenylphosphonite, NOPONMe2)) and the new pyridine-phosphonite ligand (2-ethyl(1'-methyl-1-hydroxy)pyridine-6H-dibenz[c,e][1,2]oxaphosphorin) have been used for the preparation of the mononuclear complexes [NiCl2(NOPONMe2)] 18 and [NiCl2(6)2] 19, respectively, which catalyze the oligomerisation of ethylene with activities up to 57300 mol...

Cite
Speiser F, Braunstein P, Saussine L. Nickel and iron complexes with oxazoline- or pyridine-phosphonite ligands; synthesis, structure and application for the catalytic oligomerisation of ethylene. Dalton Trans. 2004;(10):1539-45doi: 10.1039/b401792g.
Speiser, F., Braunstein, P., & Saussine, L. (2004). Nickel and iron complexes with oxazoline- or pyridine-phosphonite ligands; synthesis, structure and application for the catalytic oligomerisation of ethylene. Dalton transactions (Cambridge, England : 2003), (10), 1539-45. https://doi.org/10.1039/b401792g
Speiser, Fredy, et al. "Nickel and iron complexes with oxazoline- or pyridine-phosphonite ligands; synthesis, structure and application for the catalytic oligomerisation of ethylene." Dalton transactions (Cambridge, England : 2003) vol. ,10 (2004): 1539-45. doi: https://doi.org/10.1039/b401792g
Speiser F, Braunstein P, Saussine L. Nickel and iron complexes with oxazoline- or pyridine-phosphonite ligands; synthesis, structure and application for the catalytic oligomerisation of ethylene. Dalton Trans. 2004 May 21;(10):1539-45. doi: 10.1039/b401792g. Epub 2004 Apr 20. PMID: 15252602.
Copy Download .nbib Format: NLM
Force transmission in a packing of pentagonal particles.

Physical review. E, Statistical, nonlinear, and soft matter physics

Azéma E, Radjaï F, Peyroux R, Saussine G.
PMID: 17677434
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Jul;76(1):011301. doi: 10.1103/PhysRevE.76.011301. Epub 2007 Jul 13.

We perform a detailed analysis of the contact force network in a dense confined packing of pentagonal particles simulated by means of the contact dynamics method. The effect of particle shape is evidenced by comparing the data from pentagon...

Cite
Azéma E, Radjaï F, Peyroux R, et al. Force transmission in a packing of pentagonal particles. Phys Rev E Stat Nonlin Soft Matter Phys. 2007;76(1):011301doi: 10.1103/PhysRevE.76.011301.
Azéma, E., Radjaï, F., Peyroux, R., & Saussine, G. (2007). Force transmission in a packing of pentagonal particles. Physical review. E, Statistical, nonlinear, and soft matter physics, 76(1), 011301. https://doi.org/10.1103/PhysRevE.76.011301
Azéma, Emilien, et al. "Force transmission in a packing of pentagonal particles." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 76,1 (2007): 011301. doi: https://doi.org/10.1103/PhysRevE.76.011301
Azéma E, Radjaï F, Peyroux R, Saussine G. Force transmission in a packing of pentagonal particles. Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Jul;76(1):011301. doi: 10.1103/PhysRevE.76.011301. Epub 2007 Jul 13. PMID: 17677434.
Copy Download .nbib Format: NLM
Current Management of Symptomatic Pericardial Effusions in Cancer Patients.

JACC. CardioOncology

Besnard A, Raoux F, Khelil N, Monin JL, Saal JP, Veugeois A, Zannis K, Debauchez M, Caussin C, Amabile N.
PMID: 34396173
JACC CardioOncol. 2019 Jul 18;1(1):137-140. doi: 10.1016/j.jaccao.2019.07.001. eCollection 2019 Sep.

No abstract available.

Cite
Besnard A, Raoux F, Khelil N, et al. Current Management of Symptomatic Pericardial Effusions in Cancer Patients. JACC CardioOncol. 2019;1(1):137-140doi: 10.1016/j.jaccao.2019.07.001.
Besnard, A., Raoux, F., Khelil, N., Monin, J. L., Saal, J. P., Veugeois, A., Zannis, K., Debauchez, M., Caussin, C., & Amabile, N. (2019). Current Management of Symptomatic Pericardial Effusions in Cancer Patients. JACC. CardioOncology, 1(1), 137-140. https://doi.org/10.1016/j.jaccao.2019.07.001
Besnard, Audrey, et al. "Current Management of Symptomatic Pericardial Effusions in Cancer Patients." JACC. CardioOncology vol. 1,1 (2019): 137-140. doi: https://doi.org/10.1016/j.jaccao.2019.07.001
Besnard A, Raoux F, Khelil N, Monin JL, Saal JP, Veugeois A, Zannis K, Debauchez M, Caussin C, Amabile N. Current Management of Symptomatic Pericardial Effusions in Cancer Patients. JACC CardioOncol. 2019 Jul 18;1(1):137-140. doi: 10.1016/j.jaccao.2019.07.001. eCollection 2019 Sep. PMID: 34396173; PMCID: PMC8352300.
Copy Download .nbib Format: NLM
Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P.
PMID: 34756526
Dig Liver Dis. 2021 Oct 27; doi: 10.1016/j.dld.2021.09.012. Epub 2021 Oct 27.

BACKGROUND AND AIMS: The aims of this study were to describe the trends in the behavior of pediatric CD during the last decade and to describe the seasonal variation of disease presentation.METHODS: Patients under 18 years old and diagnosed...

Cite
Sassine S, Savoie Robichaud M, Lin YF, et al. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis. 2021;doi: 10.1016/j.dld.2021.09.012.
Sassine, S., Savoie Robichaud, M., Lin, Y. F., Djani, L., Cambron-Asselin, C., Qaddouri, M., Zekhnine, S., Grzywacz, K., Groleau, V., Dirks, M., Drouin, �. �., Halac, U., Marchand, V., Girard, C., Courbette, O., Patey, N., Dal Soglio, D., Deslandres, C., & Jantchou, P. (2021). Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, . https://doi.org/10.1016/j.dld.2021.09.012
Sassine, Samuel, et al. "Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1016/j.dld.2021.09.012
Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis. 2021 Oct 27; doi: 10.1016/j.dld.2021.09.012. Epub 2021 Oct 27. PMID: 34756526.
Copy Download .nbib Format: NLM
Reply by Authors.

The Journal of urology

Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Dupuis H, Tricard T, Hermieu N, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B.
PMID: 34383586
J Urol. 2021 Nov;206(5):1257. doi: 10.1097/JU.0000000000001954.03. Epub 2021 Aug 12.

No abstract available.

Cite
Bentellis I, El-Akri M, Cornu JN, et al. Reply by Authors. J Urol. 2021;206(5):1257doi: 10.1097/JU.0000000000001954.03.
Bentellis, I., El-Akri, M., Cornu, J. N., Brierre, T., Cousin, T., Gaillard, V., Dupuis, H., Tricard, T., Hermieu, N., Bertrand-Leon, P., Chevallier, D., Bruyere, F., Biardeau, X., Hermieu, J. F., Lecoanet, P., Capon, G., Game, X., Saussine, C., Durand, M., & Peyronnet, B. (2021). Reply by Authors. The Journal of urology, 206(5), 1257. https://doi.org/10.1097/JU.0000000000001954.03
Bentellis, Imad, et al. "Reply by Authors." The Journal of urology vol. 206,5 (2021): 1257. doi: https://doi.org/10.1097/JU.0000000000001954.03
Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Dupuis H, Tricard T, Hermieu N, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B. Reply by Authors. J Urol. 2021 Nov;206(5):1257. doi: 10.1097/JU.0000000000001954.03. Epub 2021 Aug 12. PMID: 34383586.
Copy Download .nbib Format: NLM
Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra.

World journal of urology

El-Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Gaillard V, Poussot B, Robin D, Pitout A, Beraud F, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Saussine C, Hermieu JF, Lecoanet P, Capon G, Cornu JN, Game X, Ruffion A, Peyronnet B.
PMID: 34272596
World J Urol. 2021 Dec;39(12):4449-4457. doi: 10.1007/s00345-021-03783-6. Epub 2021 Jul 17.

PURPOSE: To compare transcorporal vs bulbar artificial urinary sphincter (AUS) implantation in men with fragile urethra and to investigate the risk factors of AUS explantation in this population.METHODS: The charts of all male patients who had an AUS implantation...

Cite
El-Akri M, Bentellis I, Tricard T, et al. Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra. World J Urol. 2021;39(12):4449-4457doi: 10.1007/s00345-021-03783-6.
El-Akri, M., Bentellis, I., Tricard, T., Brierre, T., Cousin, T., Dupuis, H., Hermieu, N., Gaillard, V., Poussot, B., Robin, D., Pitout, A., Beraud, F., Bertrand-Leon, P., Chevallier, D., Bruyere, F., Biardeau, X., Monsaint, H., Corbel, L., Saussine, C., Hermieu, J. F., Lecoanet, P., Capon, G., Cornu, J. N., Game, X., Ruffion, A., & Peyronnet, B. (2021). Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra. World journal of urology, 39(12), 4449-4457. https://doi.org/10.1007/s00345-021-03783-6
El-Akri, Mehdi, et al. "Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra." World journal of urology vol. 39,12 (2021): 4449-4457. doi: https://doi.org/10.1007/s00345-021-03783-6
El-Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Gaillard V, Poussot B, Robin D, Pitout A, Beraud F, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Saussine C, Hermieu JF, Lecoanet P, Capon G, Cornu JN, Game X, Ruffion A, Peyronnet B. Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra. World J Urol. 2021 Dec;39(12):4449-4457. doi: 10.1007/s00345-021-03783-6. Epub 2021 Jul 17. PMID: 34272596.
Copy Download .nbib Format: NLM
Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study.

JGH open : an open access journal of gastroenterology and hepatology

Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P.
PMID: 34950781
JGH Open. 2021 Nov 27;5(12):1373-1381. doi: 10.1002/jgh3.12684. eCollection 2021 Dec.

BACKGROUND AND AIM: Data on factors influencing time to remission in pediatric Crohn's disease (CD) are very limited in the literature. The aim of this retrospective cohort study was to describe the trends of time to clinical remission over...

Cite
Sassine S, Zekhnine S, Qaddouri M, et al. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open. 2021;5(12):1373-1381doi: 10.1002/jgh3.12684.
Sassine, S., Zekhnine, S., Qaddouri, M., Djani, L., Cambron-Asselin, C., Savoie-Robichaud, M., Lin, Y. F., Grzywacz, K., Groleau, V., Dirks, M., Drouin, �. �., Halac, U., Marchand, V., Girard, C., Courbette, O., Patey, N., Dal Soglio, D., Deslandres, C., & Jantchou, P. (2021). Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH open : an open access journal of gastroenterology and hepatology, 5(12), 1373-1381. https://doi.org/10.1002/jgh3.12684
Sassine, Samuel, et al. "Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study." JGH open : an open access journal of gastroenterology and hepatology vol. 5,12 (2021): 1373-1381. doi: https://doi.org/10.1002/jgh3.12684
Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open. 2021 Nov 27;5(12):1373-1381. doi: 10.1002/jgh3.12684. eCollection 2021 Dec. PMID: 34950781; PMCID: PMC8674552.
Copy Download .nbib Format: NLM
Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter.

World journal of urology

de Sallmard G, Perrouin-Verbe MA, Peyronnet B, Biardeau X, Maucort-Boulch D, Chartier-Kastler E, Phé V, Even A, Joussain C, Dominique I, Amarenco G, Gamé X, Saussine C, Ruffion A.
PMID: 34626226
World J Urol. 2021 Oct 09; doi: 10.1007/s00345-021-03850-y. Epub 2021 Oct 09.

PURPOSE: To assess the efficacy and safety of intradetrusor botulinum toxin type A injections (IBTI) for idiopathic overactive bladder (iOAB) in non-neurological adults with an artificial urinary sphincter (AUS).MATERIALS AND METHODS: We retrospectively selected, in the 11 French centers,...

Cite
de Sallmard G, Perrouin-Verbe MA, Peyronnet B, et al. Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World J Urol. 2021;doi: 10.1007/s00345-021-03850-y.
de Sallmard, G., Perrouin-Verbe, M. A., Peyronnet, B., Biardeau, X., Maucort-Boulch, D., Chartier-Kastler, E., Phé, V., Even, A., Joussain, C., Dominique, I., Amarenco, G., Gamé, X., Saussine, C., & Ruffion, A. (2021). Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World journal of urology, . https://doi.org/10.1007/s00345-021-03850-y
de Sallmard, Geoffroy, et al. "Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter." World journal of urology vol. (2021). doi: https://doi.org/10.1007/s00345-021-03850-y
de Sallmard G, Perrouin-Verbe MA, Peyronnet B, Biardeau X, Maucort-Boulch D, Chartier-Kastler E, Phé V, Even A, Joussain C, Dominique I, Amarenco G, Gamé X, Saussine C, Ruffion A. Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World J Urol. 2021 Oct 09; doi: 10.1007/s00345-021-03850-y. Epub 2021 Oct 09. PMID: 34626226.
Copy Download .nbib Format: NLM
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.

Gynecologic oncology

Basaran D, Boerner T, Suhner J, Sassine D, Liu Y, Grisham RN, Tew WP, Gardner GJ, Zivanovic O, Sonoda Y, Long Roche K, Chi DS, Abu-Rustum NR, Soff GA, Jewell EL.
PMID: 34312001
Gynecol Oncol. 2021 Oct;163(1):36-40. doi: 10.1016/j.ygyno.2021.07.030. Epub 2021 Jul 24.

PURPOSE: To determine the incidence of venous thromboembolism (VTE) and define clinical risk factors associated with the development of new-onset VTE in patients receiving neoadjuvant chemotherapy (NACT) for ovarian cancer (OC).METHODS: An institutional ovarian cancer database was used to...

Cite
Basaran D, Boerner T, Suhner J, et al. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecol Oncol. 2021;163(1):36-40doi: 10.1016/j.ygyno.2021.07.030.
Basaran, D., Boerner, T., Suhner, J., Sassine, D., Liu, Y., Grisham, R. N., Tew, W. P., Gardner, G. J., Zivanovic, O., Sonoda, Y., Long Roche, K., Chi, D. S., Abu-Rustum, N. R., Soff, G. A., & Jewell, E. L. (2021). Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecologic oncology, 163(1), 36-40. https://doi.org/10.1016/j.ygyno.2021.07.030
Basaran, Derman, et al. "Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy." Gynecologic oncology vol. 163,1 (2021): 36-40. doi: https://doi.org/10.1016/j.ygyno.2021.07.030
Basaran D, Boerner T, Suhner J, Sassine D, Liu Y, Grisham RN, Tew WP, Gardner GJ, Zivanovic O, Sonoda Y, Long Roche K, Chi DS, Abu-Rustum NR, Soff GA, Jewell EL. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecol Oncol. 2021 Oct;163(1):36-40. doi: 10.1016/j.ygyno.2021.07.030. Epub 2021 Jul 24. PMID: 34312001; PMCID: PMC8511112.
Copy Download .nbib Format: NLM
Publisher Correction: Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis.

Scientific reports

Sassine J, Sousa J, Lalk M, Daniel RA, Vollmer W.
PMID: 33707645
Sci Rep. 2021 Mar 11;11(1):6156. doi: 10.1038/s41598-021-85465-2.

No abstract available.

Cite
Sassine J, Sousa J, Lalk M, et al. Publisher Correction: Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis. Sci Rep. 2021;11(1):6156doi: 10.1038/s41598-021-85465-2.
Sassine, J., Sousa, J., Lalk, M., Daniel, R. A., & Vollmer, W. (2021). Publisher Correction: Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis. Scientific reports, 11(1), 6156. https://doi.org/10.1038/s41598-021-85465-2
Sassine, Jad, et al. "Publisher Correction: Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis." Scientific reports vol. 11,1 (2021): 6156. doi: https://doi.org/10.1038/s41598-021-85465-2
Sassine J, Sousa J, Lalk M, Daniel RA, Vollmer W. Publisher Correction: Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis. Sci Rep. 2021 Mar 11;11(1):6156. doi: 10.1038/s41598-021-85465-2. PMID: 33707645; PMCID: PMC7952551.
Copy Download .nbib Format: NLM
Multi-tool formaldehyde measurement in simulated and real atmospheres for indoor air survey and concentration change monitoring.

Air quality, atmosphere, & health

Chiappini L, Dagnelie R, Sassine M, Fuvel F, Fable S, Tran-Thi TH, George C.
PMID: 21949553
Air Qual Atmos Health. 2011 Dec;4(3):211-220. doi: 10.1007/s11869-010-0102-7. Epub 2010 Oct 21.

Formaldehyde is of particular health concern since it is carcinogenic for human and ubiquitous in indoor air where people spend most of their time. Therefore, it is important to have suitable methods and techniques to measure its content in...

Cite
Chiappini L, Dagnelie R, Sassine M, et al. Multi-tool formaldehyde measurement in simulated and real atmospheres for indoor air survey and concentration change monitoring. Air Qual Atmos Health. 2010;4(3):211-220doi: 10.1007/s11869-010-0102-7.
Chiappini, L., Dagnelie, R., Sassine, M., Fuvel, F., Fable, S., Tran-Thi, T. H., & George, C. (2011). Multi-tool formaldehyde measurement in simulated and real atmospheres for indoor air survey and concentration change monitoring. Air quality, atmosphere, & health, 4(3), 211-220. https://doi.org/10.1007/s11869-010-0102-7
Chiappini, Laura, et al. "Multi-tool formaldehyde measurement in simulated and real atmospheres for indoor air survey and concentration change monitoring." Air quality, atmosphere, & health vol. 4,3 (2011): 211-220. doi: https://doi.org/10.1007/s11869-010-0102-7
Chiappini L, Dagnelie R, Sassine M, Fuvel F, Fable S, Tran-Thi TH, George C. Multi-tool formaldehyde measurement in simulated and real atmospheres for indoor air survey and concentration change monitoring. Air Qual Atmos Health. 2011 Dec;4(3):211-220. doi: 10.1007/s11869-010-0102-7. Epub 2010 Oct 21. PMID: 21949553; PMCID: PMC3156335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 73 entries